Top Massachusetts biotech companies |
| Rank | Globe 100 rank | Company | 2009 revenue (millions) | Change (percent) |
|---|---|---|---|---|
| 1 | 4 | Biogen Idec | $4,377.3 | 6.8 |
| 2 | 8 | Idera Pharmaceuticals | $34.5 | 30.5 |
| 3 | 9 | Bruker Corp. | $1,114.5 | 0.7 |
| 4 | 11 | Millipore Corp. | $1,654.4 | 3.3 |
| 5 | 18 | Waters Corp. | $1,498.7 | -4.9 |
| 6 | 23 | Cubist Pharmaceuticals | $562.1 | 29.6 |
| 7 | 34 | Genzyme Corp. | $4,515.5 | -1.9 |
| 8 | 39 | Harvard Bioscience | $85.8 | -2.6 |
| 9 | 57 | Anika Therapeutics | $40.1 | 12.2 |
SOURCE: Capital IQ, a Standard & Poor's business
Most popular Globe 100 charts
Globe 100 stories
Features
- Globe 100 Year of the short list
- No. 1 - TJX Cos. Stellar seller
- No. 2 - Raytheon Co. The best defense
- No. 4 - Biogen Idec The triple play
- No. 5 - Hanover Insurance Group Return to strength
- No. 13 - Boston Properties Quality is the strategy
- No. 14 - American Science and Engineering A force for security
- No. 16 - Sapient Corp. Science of selling
- No. 22 - Haemonetics Corp. Machines for healing
- No. 27 - Akamai Technologies Order on the Web
- Mass. Economy Global appeal
- The Century Club The class of 1910
- Executive Roundtable Where do we go now?
- Globe 100 Letter from the business editor
- Methodology How we calculate the numbers
- Road Warrior Don't leave home without these gadgets
True Green
Creative approaches to energy conservation and efficiency
- Ladybug, fly away
- Cycling may be the new golf
- What you can save if you put your mind to it
- Flying the earth-friendly skies
- A bit of flexibility goes a long way
- Full disclosure, beyond the numbers
- It's personal, not just business
- Lower emissions, one loan at a time
- The footprint is smaller, but the paycheck is bigger